Innovate UK

"Securing SFC as our first institutional investor is a significant validation of our vision."

"We’re excited to support BeamXR with their innovative solution to enable live streaming from a standalone XR headset. We are looking forward to working with the founders as they build and grow this dynamic business."

"We are very pleased to be providing further investment into Wordnerds, including a commitment from the new Northstar EIS Growth Fund. The team at Wordnerds has developed a sophisticated, market leading AI-enabled product which provides rapid and incisive analysis to consumer facing businesses. They have an impressive list of customers and have grown significantly since our initial investment. This round of funding will help them to grow their commercial and product development teams, which will enable Wordnerds to scale at pace. We’re excited to work with the team on the next stage of their development."

"Siloton has brought together a uniquely qualified team that is able to drive forward technology development at an unprecedented pace. This new support will help us take the next step towards commercialisation by shifting gear from R&D to product development. The population of individuals with retinal disease is growing. New, more affordable and accessible OCT systems like our Akepa technology will be critical to serving patients with precision and efficiency. In turn, this could help reduce preventable blindness, save healthcare providers billions of pounds, and reduce pressure on already stretched eye clinics."

"Smell can be our most powerful sense and only now are we realising the potential of technology to translate it for experience, welfare and health. This technology has enormous commercial applications which this new investment will help us unlock."

"Designing and manufacturing state-of-the-art ultrafast infra-red lasers brings huge value and efficiencies to the global healthcare market. Our new '920' builds on a decade of research and IP development to extend our product roadmap."

"when Reedah talked through her vision, Brainspark Games felt like something that had to happen and I wanted to help her make it happen"

"I couldn't be more excited and proud about this next stage in our growth. It is a landmark opportunity, a once in a lifetime moment, to build a transformative product."

"We would like to acknowledge the support of Investing Women Angels, which has not only been a key early investor, but has also supported and mentored us through its AccelerateHER programme"

"In my last company, we spoke with literally thousands of producers, financiers, distributors and brands. All of them faced the same issue, knowing what they should be creating, selling or buying, as well as how it should be positioned, what were the target markets and what audiences truly wanted. That is what North AI is here to solve"

"Everyone deserves a warm, comfortable home without costly bills and yet 11.7 million homes sit at the D energy rating or less. Sadly, energy efficiency has been the poor relation to the low-carbon technologies that grab headlines. But if your home is cold and draughty, no amount of Co2 savings is going to be better for you. We’re building Furbnow to be the go-to platform for homeowners who want advice and support as they plan and install low carbon technologies and energy efficiency elements in homes,"

"Over 30% of hypertension patients are affected by anxiety or depression, impacting their ability to manage lifestyle behaviours consistently. At Holly Health, we have supported over 30,000 people so far and are committed to innovating to solve our biggest human and healthcare challenges. This funding marks a pivotal moment – with the support of Innovate UK and the strategic investment from Modality Partnership, we are empowered to combat the complex and unresolved challenge of multimorbidity."

"We’re delighted to announce Lori as the new Chair of our Board. The wealth of her strategic experience in the digital space coupled with her sales expertise and commitment to diversity and inclusion, will support myGwork’s ambitious international growth targets,"

"We are very excited by the research and commercial potential of the Syndi Health platform. It will help us understand how better to support the mental health needs of our people and offer them the personalised digital support they need at the earliest opportunity, which is invaluable."

"We are delighted to be leading this investment round for Phlux Technology, as this innovative breakthrough is critical to the future direction of transport, communication and emission monitoring systems,"

"We are delighted to have led this investment round into Transdermal Diagnostics. The transdermal approach for glucose monitoring that Transdermal Diagnostics is developing will have a disruptive impact on the diabetes market, we are additionally excited by the company’ potential to expand into the wellness and sports nutrition industries. This funding round alongside the Innovate UK funding will help support them in this journey."

"In a post-pandemic world, web-based clinical triage is becoming an increasingly an important part of how healthcare is delivered in the UK and globally, providing a vital service and reducing the burden on healthcare teams. I have no doubt that the clinical depth of the PhysioWizard product, which has been developed over many years, will ensure that it becomes the leading digital triage solution not only in the UK but globally."

"I was determined to breastfeed my child"

"Umazi is a fantastic example of the kind of regtech innovation needed to transform an all too unglamorous but vital function – corporate due diligence. As a partner, we’re delighted to be trialling Umazi’s technology, and early indications show it will help make our own supplier onboarding process much more efficient."

"My north star is who I work with, and the level of enthusiasm, passion and desire to do great things at SleepCogni is outstanding. SleepCogni is a great example of hardware and software working together to have a truly life changing impact on patients."

"As it stands, the management of long-term health conditions is an inefficient process for patients and their GP practice. It involves multiple appointments, duplication of tests, and tons of admin. It doesn’t deliver the best for patients and also wastes valuable NHS time and resources. Abtrace is working at the interface of AI and healthcare to transform this."

"Our tech-driven approach to slow travel is not just about providing holiday experiences grounded in travelling through, rather than flying over, but about accelerating the world’s transition to sustainable travel. The past year saw the world forced to slow right down. Emerging from lockdown, many people are now choosing slower, more sustainable holidays that take them away from the crowds and help them enjoy the journey as much as the destination.We’re taking the time, and the work, out of planning and booking off the beaten path trips by train, boat and bike – and the reception we’ve had has been glowing. Our personalised, experience-based approach and on-demand WhatsApp support means holidaymakers get to spend a whole lot of time enjoying their trip and none at all managing multiple tickets, complicated timetables, and changing travel restrictions."

"We founded Sylvera because we believed that in order to reach net zero, the world will require a well-functioning and scalable carbon offset market. Such a market will only work if all participants can trust in the projects they are trading. Currently, carbon offsetting is a very opaque market with little independent assurance available to guarantee an offset has taken place. The market also lacks the transparency companies need to compare projects globally across different standards,"

"At ALT/AVE, we have all worked in financial services and we saw first-hand how much paper is wasted in banking. How banks communicate with customers is closely regulated – for good reason – however, institutions are so fearful of non-compliance that modern technology is wildly underutilised. Ultimately, this means the sector continues to waste paper, and have a negative impact on our planet."

"The goal of GlamAI is to break new ground in applications of AI for drug discovery and accelerate the path to personalized medicine in labs around the world. We are very proud of the progress we’ve made so far to validate our approach. Through our partnership with King’s College London, GlamAI will collaborate with experts in glioblastoma multiforme and will secure access to disease cell-lines that best represent the tumor in patients. The funding received from Innovate UK is key to progress this highly innovative project and to accelerate the path to treatment for this deadly disease."

"At a time when the value of tech degrees is in decline, there is an urgent need for disruption in cyber-security education. At CAPSLOCK, we’re determined to drive this disruption. By unlocking the potential of adults in the UK, and eliminating the financial barriers to reskilling, we’re changing the face of cyber-security and making it more accessible to people of all backgrounds."

"When I took over the farm, harvest workers would write their name on a piece of cornflake packet and stick it to the box they picked,"

"As a UK health tech scaleup, we were delighted to receive this funding to deliver further improvements in homecare innovation. COVID-19 has both highlighted the urgent need for a more connected experience in the domiciliary care sector, as well as driven the rise in demand for the elderly to stay in their homes. We have purpose-built the CareLineLive solution to complete the circle of care, giving homecare staff a platform to easily track and record their patients’ care, families the insight into their loved ones’ care, and patients the peace of mind that their care is being monitored seamlessly. The next step will be increased data insights enabling more proactive interventions. This will ultimately help to integrate person-centred care between all care providers in the future."

"Digital maps have become part of everyday life for many but using them indoors still poses problems, given the lack of reliable positioning. Our platform overcomes this, providing a better experience for vistors to any large complex spaces, whilst enabling better decisions by operators. This loan will further help us to fast track its development and open up global opportunities for Living Map."

"This next round of Innovate UK funding is a huge endorsement of everything we are achieving with Archer. For us, it’s always been about how we accelerate a major step-change in the speed, efficiency and affordability of clinical studies."

"We’re delighted to support Veo in securing this funding. The RAIA project is focussed on helping innovative North businesses secure finance for growth by attracting co-investment from Angels. Manchester and the wider North are a hotbed of innovation, and I’m delighted we’ve been able to help another disruptive business grow their offer and reach new markets."

"Machine learning is more and more integral to products and services we use every day – and to decisions that businesses and governments make about us – but without a widely-accessible way of identifying and eliminating bias, it could cause significant damage to our society by further entrenching discriminatory decision-making despite our best intentions and without us even realising."

"Our vision for Glimpse Protocol is to set new standards for privacy in advertising, becoming the kitemark that consumers can trust. This investment enables us to roll out our technology that delivers valuable, effective advertising while respecting consumer privacy. With consumers, regulators and tech giants taking action on data privacy, the digital advertising industry is seeking a solution that can weather technical changes and increasingly stringent privacy requirements. Unlike our competitors, who offer partial stopgaps, Glimpse Protocol provides a uniquely clear vision of how the problem can and must be tackled."

"We are thrilled to back this innovative group out of the UK, there have been many attempts at small satellite propulsion innovation over the past decade, but they have been marginal improvements on pre-existing technology, Magdrive is the first step-change improvement offering the best of chemical and electric propulsion in a single system."

"Fixed schedules lead to static groupings of the same people in the same office at the same time. A company’s culture is the mix of all its people, not just those in the office on Mondays. Catering for flexible working practices will not only maximise staff interactions remotely and physically but create a more equal playing field for a diverse workforce. We can’t sleepwalk into a situation where employees who are less present in the office or work on different days to other key stakeholders, miss out on opportunities. It will lead to the people who are remote most often or on fixed days getting promoted less or being overlooked."

"This is a really exciting time for enee.io. The Innovate UK grant will enable us to expedite the development process and bring forward the launch of a viable product which we believe will have a significant impact on both the future of industrial battery management in the UK and the uptake of renewable power globally, particularly in developing economies."

"With the ongoing pandemic, it’s more critical than ever that organisations are able to access immersive technology that can help deliver realistic, remote training."

"With COVID-19 still an ever-present challenge in the UK and across the globe, our working lives, social encounters, and travel plans are continually being disrupted. Businesses like Navenio have stepped up to the challenge and produced technology which aims to solve these issues. Those awarded funding from our competition will support the UK in delivering potential solutions and services to facilitate our recovery from the pandemic."

"In these difficult times we have seen the best of British business innovation. The pandemic is not just a health emergency but one that impacts society and the economy"

"This latest investment shows the belief in the BeneTalk product and team, and helps us move closer to transforming the speech therapy experience for millions of people with our AI-driven speech-tracking technology."

"Over the last year, we have been redefining fitness and challenging people’s perceptions of what a fun and effective workout is, providing an alternative for people who want to keep fit but are unmotivated by the traditional fitness offerings"

"Bringing validation of our novel gene therapy and the opportunity to accelerate the development of our pipeline, we are delighted to receive this grant from Innovate UK. Ikarovec believes its approach has great potential in the treatment of the debilitating disease of wet AMD, with significant advantages over existing therapies and those in development."

"We’re incredibly honoured and proud to have received this grant. Most of the funds will be used towards further development and content for the app as we have high expectations to deliver a platform that is contextually smart as well as impactful with practical, actionable steps and content."

"Coronary heart disease is endemic worldwide but far too often the decision to implant a stent is based on sub-optimal information. Our technology addresses the ‘grey zone’ of patients where the requirement for a stent is currently difficult to determine. By using advanced optical sensing technology, we hope to significantly improve the accuracy of current treatments, saving healthcare costs and preventing unnecessary operations for patients that could be treated with medicines."

"We are in the midst of an electric revolution, with many businesses, councils and individuals looking to make the transition to alternative fuelled vehicles"

"We are delighted to announce Bloc Ventures as our first institutional investor and look forward to working together during our next stage of growth."

"Sleep is vital both to our mental and physical health. As mental health experts we need to find ways to help people improve their sleep quality, especially those with sleep problems."

"I was shocked that despite being a treatable condition, pneumonia kills one million children under-five every year – more than HIV, malaria, and TB combined. When I realised these deaths can be avoided through early diagnosis, I became obsessed with finding a way to solve the problem."

"Using the information from the app, users can choose to avoid certain high pollution areas, reducing the amount of emissions inhaled, and hopefully divert traffic away from those areas, thereby reducing the levels of pollution – a positive result for everyone."

"After seeing Tended pitch a couple of times at Minerva events, one of Blackfinch Ventures directors expressed an interest in investing. Initially, I thought it was just him acting as an individual Angel, so when I heard the investment was to be through Blackfinch and they were interested in investing £810k, it came as quite a shock! It also came at just the right time as we had a number of very exciting opportunities opening up, which required a much larger cash injection than previously anticipated."

"This partnership and funding clearly indicate the importance and value of artificial intelligence as a new approach to support UK SMEs and reinvigorate drug discovery. Our aim is to help deliver a platform which is of high value to UK SMEs to advance their own drug discovery projects faster and more efficiently by accessing otherwise inaccessible, complex technical expertise"

"We’re thrilled to have been given the opportunity by Innovate UK to prove that professional open source is the only viable solution to the NHS’s complex software needs. Innovate UK understood that we have ambitious aims to transform the NHS’s approach to digital technology, helping to create software that is the perfect clinical fit for today and adaptable for tomorrow saving lives and money simultaneously."

"Throughout my international practice in speech therapy, I have wanted to develop an innovative treatment that will help people communicate again after a stroke, brain injury, Parkinson’s or Dementia."

"Adequate data curation underpins so much of the future success of research and development in science and Biorelate is continually investing in innovative ways to improve this. What really excites me about this project is the prospect of bringing two completely different, game-changing technologies together to achieve something entirely novel. We can’t wait to start!"

"We are delighted to support Mendelian as part of our work into rare diseases. With over 3 million rare disease patients in the UK, innovative technologies using data analytics and machine learning like this are increasingly vital in ensuring that these conditions are diagnosed earlier to provide more targeted and personalised treatment for patients."

"We are very excited about our current progress in research and development. Validation and further development is ongoing, and we are planning our clinical trials, in collaboration with scientists from both Universities in Sheffield and internationally, in the Netherlands. We are committed to use our technology to help people that suffer from issues related to sleep."